肿瘤领域药物开发早期热门靶点研究报告AACR2023-2024-智慧芽.pdf,关于智慧芽生物医药 智慧芽生物医药作为行业的创新先锋,精心构建了由Synapse新药情报库、Bio生物序列 数据库和Chemical化学结构数据库三大核心产品组成的综合数据服务平台。这一平台旨在为 生物医药领域的全
2023.Requests to withdraw late-breaking or clinical trials abstracts will be accepted throughMonday, March 6, 2023.Withdrawal requests must be sent by email toabstractchanges@aacr.org. Withdrawal requests must include the Abstract Control Number and title as well as an explanation of the reason for...
2023.Requests to withdraw late-breaking or clinical trials abstracts will be accepted throughMonday, March 6, 2023.Withdrawal requests must be sent by email toabstractchanges@aacr.org. Withdrawal requests must include the Abstract Control Number and title as well as an explanation of the reason for...
智慧芽:肿瘤领域药物开发早期热门靶点研究报告(AACR 2023-2024)(56页).pdf,点击即可下载。包含的报告内容,文档格式为PDF,大小5.62MB,页数56页,字数约26939字,欢迎会员下载
Frequency: Annual Country of Study: Any country Application Procedure: To be considered, please submit an electronic version of a dissertation abstract that is no longer than 15 double-spaced pages (including appendices, tables, figures, and references). Closing Date: 1 January Additional Information...
文件列表: 医药魔方:2023AACR新药开发机会分析.pdf 下载文档 资源简介 > 载入中...手动刷新 1/30页 载入中...手动刷新 2/30页 载入中...手动刷新 3/30页 载入中...手动刷新 4/30页 载入中... 5/30页 载入中... 6/30页 载入中...
Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual Meeting April 11, 2023 New translational and clinical biomarker data from Zai Lab's global oncology program ZL-1211 will be featured in a poster presentation (Abstract presentation number: 4531) SHANGHAI and CAMBRIDGE...
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics September 18, 2023 CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: ...
据智慧芽-新药情报库收录,2023 年青煜医药于 AACR 年会公开了该品种部分信息,题目为“Abstract 6271:Discovery of BR1733 for the treatment of SWI/SNF deficient or 47、highly vascularized solid tumor”。27 该研究发现了一种用于治疗 SWI/SNF 缺失或高血管化实体肿瘤的药物 BR1733。研究表明,EZH2 的激活...
Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual Meeting April 11, 2023 New translational and clinical biomarker data from Zai Lab's global oncology program ZL-1211 will be featured in a poster presentation (Abstract presentation number: 4531) SHANGHAI and CAMBRIDGE...